A recent study by Dr. Jordan Verplank, Assistant Professor in the Department of Anatomy, Physiology, and Genetics at the ...

SAVANNAH, Georgia — There’s no medical treatment for Charcot-Marie-Tooth (CMT) disease, a debilitating neurologic disorder that’s both progressive and incurable. But now, nerve specialists ...

French biotech Pharnext has seen the value of its shares collapse after it revealed that its lead drug, a treatment for Charcot-Marie-Tooth (CMT) disease, failed to make the grade in a phase 3 trial.

Mitochondria In Motion Inc. has identified new N-(trans-4-hydroxycyclohexyl)-6-phenylhexanamide derivatives acting as mitofusin activators and reported to be useful for the treatment of Alzheimer’s, ...

The Grammy-winning musician went public about living — and performing — with a neurological condition called ...

Sara McCready launched Gnome and Away Travel in February with her husband Kevin. Becoming a Hays Travel Explorer franchisee ...

Avicenna received a patent covering ROCK inhibitor compounds for ALS, Parkinson’s, and other neurodegenerative conditions.

The SynGAP Research Fund 501(c)(3) has awarded a pair of grants to Dr. Clement Chow, a geneticist and Associate Professor in the Department of Human Genetics at the University of Utah. These grants ...

An east Auckland teenager with a rare genetic condition is grateful for having received equipment that will make it easier ...

Alan Jackson's next farewell tour concert is on Saturday, Nov. 16, 2024, in Salt Lake City, Utah. In this file photo, he ...

Thousands of people woke up to news that their bank is randomly closing down, and they must move their money ASAP.

The next concert in Alan Jackson's farewell tour is on Saturday, Oct. 26, 2024, in Kansas City, Missouri. In this file photo, ...